CompletedNot applicableNCT03820557

Decision Counseling Program in Increasing Shared Decision Making and Clinical Trial Participation in Patients With Stage 0-IV Lung Cancer (Free to Breathe)

This clinical trial studies how well the Decision Counseling Program works in increasing patient-physician shared decision making and participation in clinical trials for lung cancer patients. Decision aids help provide patients with information that may help them select a course of action related to their cancer care when more than one alternative is available. It also encourages shared decision making allowing patients and their providers to make health decisions together. Determining how patients make decisions about participating in a clinical trial may help doctors facilitate patient decision making and improve participation in lung cancer clinical trials.

Checked against the public recordLast updated Apr 29, 2025 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations1
SponsorSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Interventions being studied
Other: Educational Intervention
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Patients diagnosed with lung cancer (Stages 0, 1, 2, 3, 4) * Lung cancer patients for which there is an available interventional clinical trial open at Jefferson Kimmel Cancer Center * Patients being treated by a lung medical oncologist on the Center City Campus of Thomas Jefferson University * Able to provide informed consent * English-speaking Exclusion Criteria: * Inability to communicate in English * Unable to provide informed consent * Not eligible for an open, actively accruing interventional trial at Jefferson

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Sidney Kimmel Cancer Center at Thomas Jefferson UniversityPhiladelphia, Pennsylvania

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 29, 2025. Always confirm current availability with the study team.

View original record ↗